Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Apyx Medical Corp - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
APYX
Nasdaq
3841
https://apyxmedical.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Apyx Medical Corp
Here's What Apyx Medical Corporation's (NASDAQ:APYX) Shareholder Ownership Structure Looks Like
- Jun 15th, 2022 5:09 pm
Why Apyx Medical Shares Are Trading Higher Today?
- May 26th, 2022 4:20 pm
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® Cosmetic Technology in Dermal Resurfacing Procedures
- May 26th, 2022 12:30 pm
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in June
- May 25th, 2022 8:05 pm
Those who invested in Apyx Medical (NASDAQ:APYX) five years ago are up 70%
- May 16th, 2022 4:53 pm
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
- May 12th, 2022 12:15 pm
Apyx Medical Corporation Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook
- May 12th, 2022 11:00 am
Quidel (QDEL) Q1 Earnings and Revenues Top Estimates
- May 4th, 2022 9:55 pm
LeMaitre Vascular (LMAT) Q1 Earnings Miss Estimates
- Apr 28th, 2022 9:55 pm
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022
- Apr 4th, 2022 8:05 pm
Apyx Medical Corporation Announces FDA 510(k) Submission with Clinical Study Support for the Use of the Renuvion® APR Handpiece for Aesthetic Procedures to Improve Appearance of Lax Skin
- Apr 4th, 2022 11:00 am
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Outlook
- Mar 17th, 2022 11:00 am
Apyx Medical Corporation Notified of Pending FDA Medical Device Safety Communication Related to its Advanced Energy Products
- Mar 14th, 2022 11:00 am
Lantheus Announces Appointment of Minnie Baylor-Henry as New Board Member
- Mar 1st, 2022 9:05 pm
Molina (MOH) to Join S&P 500 Driven by Medicare Performance
- Feb 28th, 2022 5:01 pm
Apyx Medical Submits Additional FDA 510(k) For Expanded Use Of Renuvion In Dermatological Procedures
- Feb 17th, 2022 5:26 pm
Apyx Medical Corporation Announces Peer-Reviewed Publication Featuring Results from the U.S. IDE Clinical Study Evaluating the Renuvion® Dermal Handpiece Using Apyx’s Helium Plasma Technology for Dermal Resurfacing Procedures
- Feb 17th, 2022 12:30 pm
A Look At The Intrinsic Value Of Apyx Medical Corporation (NASDAQ:APYX)
- Feb 15th, 2022 10:08 am
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 17, 2022
- Jan 27th, 2022 12:30 pm
Medtronic (MDT) Undertakes Investment to Advance STEM Education
- Jan 24th, 2022 2:52 pm
Scroll